Updated
Updated · Ars Technica · Sep 9
FDA Clears 2026 Flu, COVID Shots as Pharmacies Begin Fall Rollout
Updated
Updated · Ars Technica · Sep 9

FDA Clears 2026 Flu, COVID Shots as Pharmacies Begin Fall Rollout

3 articles · Updated · Ars Technica · Sep 9

Summary

  • Updated flu and COVID-19 vaccines have already started reaching pharmacies after FDA approval for the 2026 respiratory virus season.
  • Major insurers will keep covering the seasonal shots at no cost through at least the end of 2027, helping preserve access despite federal vaccine-policy turmoil.
  • That rollout is proceeding even though the CDC vaccine advisory committee is effectively sidelined after a judge in March voided changes made by Kennedy-installed members.
  • State and local health officials still expect a largely normal fall campaign and are focusing on lifting vaccination rates as schools reopen and virus season approaches.

Insights

With the highly evasive Super-K flu strain circulating, can this season's updated vaccines truly prevent a massive winter outbreak?
As COVID and flu viruses rapidly mutate, is getting multiple updated vaccines at once the ultimate shield or a gamble?
The first mRNA flu shot is here, but does its surprising 26.6 percent efficacy rate actually outsmart traditional vaccines?